These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32989677)

  • 21. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.
    Park HH; Kim HN; Kim H; Yoo Y; Shin H; Choi EY; Bae JS; Lee W
    Sci Adv; 2020 Jul; 6(31):. PubMed ID: 32937590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive mapping of immune perturbations associated with severe COVID-19.
    Kuri-Cervantes L; Pampena MB; Meng W; Rosenfeld AM; Ittner CAG; Weisman AR; Agyekum RS; Mathew D; Baxter AE; Vella LA; Kuthuru O; Apostolidis SA; Bershaw L; Dougherty J; Greenplate AR; Pattekar A; Kim J; Han N; Gouma S; Weirick ME; Arevalo CP; Bolton MJ; Goodwin EC; Anderson EM; Hensley SE; Jones TK; Mangalmurti NS; Luning Prak ET; Wherry EJ; Meyer NJ; Betts MR
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32669287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
    Qin C; Zhou L; Hu Z; Zhang S; Yang S; Tao Y; Xie C; Ma K; Shang K; Wang W; Tian DS
    Clin Infect Dis; 2020 Jul; 71(15):762-768. PubMed ID: 32161940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-6 as a potential biomarker of COVID-19 progression.
    Ulhaq ZS; Soraya GV
    Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
    [No Abstract]   [Full Text] [Related]  

  • 26. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
    Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
    Front Immunol; 2021; 12():626235. PubMed ID: 33584733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
    Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
    Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Chen L; Liu HG; Liu W; Liu J; Liu K; Shang J; Deng Y; Wei S
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):203-208. PubMed ID: 32164089
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and pathological investigation of patients with severe COVID-19.
    Li S; Jiang L; Li X; Lin F; Wang Y; Li B; Jiang T; An W; Liu S; Liu H; Xu P; Zhao L; Zhang L; Mu J; Wang H; Kang J; Li Y; Huang L; Zhu C; Zhao S; Lu J; Ji J; Zhao J
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
    McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
    Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical characteristics of 71 patients with coronavirus disease 2019.
    Xiao M; Hou M; Liu X; Li Z; Zhao Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of clinical characteristics of 405 patients with COVID-19.
    Zhan T; Liu M; Tang Y; Han Z; Cheng X; Deng J; Chen X; Tian X; Huang X
    J Int Med Res; 2020 Aug; 48(8):300060520949039. PubMed ID: 32865077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.
    Townsend L; Dyer AH; Jones K; Dunne J; Mooney A; Gaffney F; O'Connor L; Leavy D; O'Brien K; Dowds J; Sugrue JA; Hopkins D; Martin-Loeches I; Ni Cheallaigh C; Nadarajan P; McLaughlin AM; Bourke NM; Bergin C; O'Farrelly C; Bannan C; Conlon N
    PLoS One; 2020; 15(11):e0240784. PubMed ID: 33166287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.
    Liu G; Zhang S; Hu H; Liu T; Huang J
    Scott Med J; 2020 Nov; 65(4):154-160. PubMed ID: 32865157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line.
    Ciccullo A; Borghetti A; Zileri Dal Verme L; Tosoni A; Lombardi F; Garcovich M; Biscetti F; Montalto M; Cauda R; Di Giambenedetto S;
    Int J Antimicrob Agents; 2020 Aug; 56(2):106017. PubMed ID: 32437920
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
    Liu Y; Liao W; Wan L; Xiang T; Zhang W
    Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.